524506 — Coral Laboratories Balance Sheet
0.000.00%
- IN₹1.75bn
- IN₹736.86m
- IN₹1.15bn
- 61
- 62
- 21
- 46
Annual balance sheet for Coral Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 214 | 243 | 300 | 278 | 309 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 527 | 524 | 461 | 498 | 533 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,286 | 1,308 | 1,235 | 1,539 | 1,765 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 209 | 245 | 243 | 233 | 242 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,675 | 1,899 | 1,743 | 2,057 | 2,295 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 276 | 255 | 119 | 249 | 250 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 309 | 338 | 195 | 282 | 283 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 1,366 | 1,561 | 1,548 | 1,775 | 2,012 |
| Total Liabilities & Shareholders' Equity | 1,675 | 1,899 | 1,743 | 2,057 | 2,295 |
| Total Common Shares Outstanding |